Profil
Yi Pin Huang is the founder of PharmaDax Inc. established in 2008.
Currently, he holds the position of Chairman in PharmaDax USA, Inc., PharmaDax (Hong Kong) Ltd., Ansbach Acoustic International Ltd., and is a Director in Reach High Enterprises Ltd., Master Brand Global Corp., Quantex Holding Ltd.
and a Member-Supervisory Board in Shengqun Pharmaceutical Co., Ltd.
Mr. Huang has a graduate degree from St. John's University and an undergraduate degree from Taipei Medical University.
Aktive Positionen von Yi Pin Huang
Unternehmen | Position | Beginn |
---|---|---|
PharmaDax USA, Inc. | Vorsitzender | - |
PharmaDax (Hong Kong) Ltd. | Vorsitzender | - |
Reach High Enterprises Ltd. | Direktor/Vorstandsmitglied | - |
Master Brand Global Corp. | Direktor/Vorstandsmitglied | - |
Quantex Holding Ltd. | Direktor/Vorstandsmitglied | - |
Ansbach Acoustic International Ltd. | Vorsitzender | - |
Shengqun Pharmaceutical Co., Ltd. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Yi Pin Huang
Unternehmen | Position | Ende |
---|---|---|
PHARMADAX INC. | Gründer | - |
Ausbildung von Yi Pin Huang
St. John's University | Graduate Degree |
Taipei Medical University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 8 |
---|---|
PharmaDax Inc.
PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan. | Health Technology |
PharmaDax USA, Inc. | |
PharmaDax (Hong Kong) Ltd. | |
Reach High Enterprises Ltd. | |
Master Brand Global Corp. | |
Quantex Holding Ltd. | |
Ansbach Acoustic International Ltd. | |
Shengqun Pharmaceutical Co., Ltd. |